AstraZeneca made $10 billion offer for obesity drugmaker Rhythm, sources say

3

By Sabrina Valle, Milana Vinn and Amy-Jo Crowley Nov 4 (Reuters) – AstraZeneca made an offer of about $10 billion to acquire obesity drugmaker Rhythm Pharmaceuticals, according to three people

(The article has been published through a syndicated feed. Except for the headline, the content has been published verbatim. Liability lies with original publisher.)